This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Gold, Michael
| Item Type | Name |
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Academic Article
|
Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era.
|
|
Academic Article
|
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
|
|
Academic Article
|
A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus paraaortic irradiation for stage III endometrial cancer.
|
|
Academic Article
|
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.
|
|
Academic Article
|
Carcinosarcoma of the ovary-a case series.
|
|
Academic Article
|
Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
|
|
Academic Article
|
Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer.
|
|
Academic Article
|
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
|
|
Academic Article
|
Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.
|
|
Academic Article
|
Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.
|
|
Academic Article
|
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer.
|
|
Academic Article
|
Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population?
|
|
Academic Article
|
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
|